Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Akcea Therapeutics

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

INOTERSEN SODIUM

Brand Name : TEGSEDI

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : EQ 284MG BASE/1.5ML (EQ 189.3MG BASE/ML)

Packaging :

Approval Date : 2018-10-05

Application Number : 211172

Regulatory Info : DISCN

Registration Country : USA

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Inotersen Sodium

Brand Name : Tegsedi

Dosage Form : Solution For Injection

Dosage Strength : 284mg

Packaging :

Approval Date : 06/07/2018

Application Number : 20171106000073

Regulatory Info : Approved

Registration Country : Sweden

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Inotersen Sodium

Brand Name : Tegsedi

Dosage Form : Injectable Solution In Pre-Filled Syringe

Dosage Strength : 284MG

Packaging :

Approval Date : 2019-09-09

Application Number : 1181296002

Regulatory Info : Authorized

Registration Country : Spain

blank